Diabetic Ketoacidosis Latest Advances

Glycemic Outcomes with an Open-Source Automated Insulin Delivery System in Adults with Type 1 Diabetes: A 1-Year Real-World Observational Study.

Journal: Diabetes technology & therapeutics

Published: January 22, 2026

The Development and Validation of Multivariable Electronic Health Record-Based Models to Predict Diabetic Ketoacidosis-Related Hospitalizations for Adults with Type 1 Diabetes.

Journal: Diabetes technology & therapeutics

Published: January 20, 2026

A Case of Perforated Ileum Due to Gangrenous Ischemic Enteritis after Cardiopulmonary Arrest with Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic Syndrome

Journal: Gan to kagaku ryoho. Cancer & chemotherapy

Published: January 19, 2026

Automated Insulin Delivery Systems Are Safe During Prolonged Religious Jewish Fasting Among Adolescents and Young Adults With Type 1 Diabetes.

Journal: Journal of diabetes science and technology

Published: January 19, 2026

A Case Report of an Elderly Type 2 Diabetes Mellitus Complicated with Fulminant Type 1 Diabetes Mellitus.

Journal: Clinical laboratory

Published: January 16, 2026

Population Screening for Type 1 Diabetes in Pediatrics via Well-Child Visits: Barriers and Facilitators to Implementation.

Journal: Diabetes spectrum : a publication of the American Diabetes Association

Published: January 12, 2026

Psychological Impact of Type 1 Diabetes: A Focus on Disordered Eating Behavior in Female Adolescents.

Journal: Diabetes spectrum : a publication of the American Diabetes Association

Published: January 12, 2026

Pregnancy Outcomes in Patients with Type 1 Diabetes Using Continuous Glucose Monitoring.

Journal: American journal of perinatology

Published: January 12, 2026

Diabetic Ketoacidosis Unveiling Severe Hypertriglyceridemia and Acute Mild Pancreatitis: A Rare Initial Manifestation of Type 2 Diabetes Mellitus.

Journal: The American journal of case reports

Published: January 06, 2026

Comparative Effectiveness of Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors Versus Glucagon-Like Peptide-1 (GLP-1) Agonists on Cardiovascular and Renal Outcomes in Type 2 Diabetes: A Systematic Review and Network Meta-Analysis.

Journal: Cureus

Published: January 06, 2026

Unmasking the risk: euglycemic diabetic ketoacidosis induced by GLP-1 agonist in type 2 diabetes.

Journal: Proceedings (Baylor University. Medical Center)

Published: January 05, 2026

Olanzapine and the Spectrum of Drug-Induced Diabetes: Unveiling Dual Risk Factors for Type 2 Diabetes and Acute-onset Ketoacidosis.

Journal: Internal medicine (Tokyo, Japan)

Published: January 04, 2026